| # | Side effect | Count |
|---|---|---|
| 0 | DISEASE PROGRESSION | 239 |
| 1 | OFF LABEL USE | 168 |
| 2 | LYMPHOMA | 165 |
| 3 | DEATH | 66 |
| 4 | DRUG INEFFECTIVE | 47 |
| 5 | DIFFUSE LARGE B-CELL LYMPHOMA | 42 |
| 6 | NEUTROPENIA | 39 |
| 7 | BLOOD LACTATE DEHYDROGENASE INCREASED | 38 |
| 8 | MALIGNANT NEOPLASM PROGRESSION | 38 |
| 9 | COVID-19 | 30 |
| # | Side effect | Count | Frequency |
|---|---|---|---|
| 0 | CD19 EXPRESSION DECREASED | 1 | 0.3333 |
| 1 | CD19 ANTIGEN LOSS | 2 | 0.1250 |
| 2 | BLASTOCYSTIS INFECTION | 5 | 0.0575 |
| 3 | DIALYSIS DISEQUILIBRIUM SYNDROME | 1 | 0.0500 |
| 4 | TRANSPLANT ASSOCIATED THROMBOTIC MICROANGIOPATHY | 1 | 0.0400 |
| 5 | COR PULMONALE CHRONIC | 6 | 0.0319 |
| 6 | CSF LYMPHOCYTE COUNT ABNORMAL | 1 | 0.0278 |
| 7 | CATHETER SITE THROMBOSIS | 7 | 0.0255 |
| 8 | RHODOCOCCUS INFECTION | 4 | 0.0241 |
| 9 | FULL BLOOD COUNT | 1 | 0.0175 |